ASX - By Stock
|
AVR |
Re:
Ann: Waiver from ASX Listing Rule 7.1
|
|
KSD
|
16 |
3.9K |
0 |
07/08/25 |
07/08/25 |
ASX - By Stock
|
16
|
3.9K
|
0
|
|
ASX - By Stock
|
DNA |
Re:
Ann: Results of Scheme Meeting
|
|
KSD
|
9 |
1.6K |
3 |
04/08/25 |
04/08/25 |
ASX - By Stock
|
9
|
1.6K
|
3
|
|
ASX - By Stock
|
BCI |
Re:
Ann: Quarterly Activities Report
|
|
KSD
|
13 |
4.9K |
0 |
31/07/25 |
31/07/25 |
ASX - By Stock
|
13
|
4.9K
|
0
|
|
ASX - By Stock
|
EML |
Re:
Ann: Change in substantial holding from WAM/WMI
|
|
KSD
|
10 |
6.0K |
3 |
23/07/25 |
23/07/25 |
ASX - By Stock
|
10
|
6.0K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
CEO interview
|
|
KSD
|
65 |
27K |
5 |
17/07/25 |
17/07/25 |
ASX - By Stock
|
65
|
27K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
CEO interview
|
|
KSD
|
65 |
27K |
0 |
15/07/25 |
15/07/25 |
ASX - By Stock
|
65
|
27K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
More Competition
|
|
KSD
|
11 |
4.0K |
2 |
04/07/25 |
04/07/25 |
ASX - By Stock
|
11
|
4.0K
|
2
|
|
ASX - By Stock
|
BCI |
Re:
Valuation
|
|
KSD
|
27 |
10K |
2 |
27/06/25 |
27/06/25 |
ASX - By Stock
|
27
|
10K
|
2
|
|
ASX - By Stock
|
BCI |
Re:
Valuation
|
|
KSD
|
27 |
10K |
1 |
26/06/25 |
26/06/25 |
ASX - By Stock
|
27
|
10K
|
1
|
|
ASX - By Stock
|
EML |
Re:
Ann: Class Action Update
|
|
KSD
|
22 |
11K |
5 |
26/06/25 |
26/06/25 |
ASX - By Stock
|
22
|
11K
|
5
|
|
ASX - By Stock
|
EML |
Re:
Ann: Change in substantial holding for from WMI, WAM
|
|
KSD
|
26 |
17K |
0 |
20/06/25 |
20/06/25 |
ASX - By Stock
|
26
|
17K
|
0
|
|
ASX - By Stock
|
BCI |
Re:
BCI Beautiful Compounding Investment
|
|
KSD
|
1.6K |
755K |
4 |
04/06/25 |
04/06/25 |
ASX - By Stock
|
1.6K
|
755K
|
4
|
|
ASX - By Stock
|
EML |
Re:
Ann: Change in substantial holding for from WMI, WAM
|
|
KSD
|
26 |
17K |
4 |
29/05/25 |
29/05/25 |
ASX - By Stock
|
26
|
17K
|
4
|
|
ASX - By Stock
|
EML |
Re:
Ann: Change in substantial holding for from WMI, WAM
|
|
KSD
|
26 |
17K |
5 |
28/05/25 |
28/05/25 |
ASX - By Stock
|
26
|
17K
|
5
|
|
ASX - By Stock
|
BCI |
Re:
Ann: Investor Roadshow Presentation
|
|
KSD
|
55 |
19K |
7 |
28/05/25 |
28/05/25 |
ASX - By Stock
|
55
|
19K
|
7
|
|
ASX - By Stock
|
BCI |
Re:
BCI Beautiful Compounding Investment
|
|
KSD
|
1.6K |
755K |
5 |
24/05/25 |
24/05/25 |
ASX - By Stock
|
1.6K
|
755K
|
5
|
|
ASX - By Stock
|
BCI |
Re:
Ann: Investor Roadshow Presentation
|
|
KSD
|
55 |
19K |
3 |
22/05/25 |
22/05/25 |
ASX - By Stock
|
55
|
19K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
What price Australian were we when we listed on the NASDAQ.
|
|
KSD
|
9 |
6.1K |
9 |
22/05/25 |
22/05/25 |
ASX - By Stock
|
9
|
6.1K
|
9
|
|
ASX - By Stock
|
BCI |
Re:
Ann: Investor Roadshow Presentation
|
|
KSD
|
55 |
19K |
0 |
19/05/25 |
19/05/25 |
ASX - By Stock
|
55
|
19K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
CEO interview
|
|
KSD
|
65 |
27K |
1 |
16/05/25 |
16/05/25 |
ASX - By Stock
|
65
|
27K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
CEO interview
|
|
KSD
|
65 |
27K |
6 |
08/05/25 |
08/05/25 |
ASX - By Stock
|
65
|
27K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
CEO interview
|
|
KSD
|
65 |
27K |
14 |
07/05/25 |
07/05/25 |
ASX - By Stock
|
65
|
27K
|
14
|
|
ASX - By Stock
|
BCI |
Re:
Ann: March 2025 Quarterly Update
|
|
KSD
|
18 |
7.8K |
0 |
29/04/25 |
29/04/25 |
ASX - By Stock
|
18
|
7.8K
|
0
|
|
ASX - By Stock
|
BCI |
Re:
Ann: Commonwealth Government Approval Received for GMMP
|
|
KSD
|
41 |
16K |
4 |
22/04/25 |
22/04/25 |
ASX - By Stock
|
41
|
16K
|
4
|
|
ASX - By Stock
|
BCI |
Re:
Ann: Commonwealth Government Approval Received for GMMP
|
|
KSD
|
41 |
16K |
1 |
16/04/25 |
16/04/25 |
ASX - By Stock
|
41
|
16K
|
1
|
|
ASX - By Stock
|
EML |
Re:
eml shine lawyers class action
|
|
KSD
|
18 |
13K |
2 |
11/04/25 |
11/04/25 |
ASX - By Stock
|
18
|
13K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Clinical Milestone - 100 patients treated with DurAVR THV
|
|
KSD
|
35 |
16K |
1 |
31/03/25 |
31/03/25 |
ASX - By Stock
|
35
|
16K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Annual Report to shareholders
|
|
KSD
|
60 |
28K |
0 |
25/03/25 |
25/03/25 |
ASX - By Stock
|
60
|
28K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Annual Report to shareholders
|
|
KSD
|
60 |
28K |
1 |
24/03/25 |
24/03/25 |
ASX - By Stock
|
60
|
28K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Annual Report to shareholders
|
|
KSD
|
60 |
28K |
4 |
22/03/25 |
22/03/25 |
ASX - By Stock
|
60
|
28K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Annual Report to shareholders
|
|
KSD
|
60 |
28K |
0 |
21/03/25 |
21/03/25 |
ASX - By Stock
|
60
|
28K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Anteris Reports One-Year Patient Outcomes for DurAVR THV
|
|
KSD
|
3 |
1.9K |
0 |
21/03/25 |
21/03/25 |
ASX - By Stock
|
3
|
1.9K
|
0
|
|
ASX - By Stock
|
BCI |
Re:
BCI Beautiful Compounding Investment
|
|
KSD
|
1.6K |
755K |
2 |
19/03/25 |
19/03/25 |
ASX - By Stock
|
1.6K
|
755K
|
2
|
|
ASX - By Stock
|
DNA |
Re:
Ann: DNA enters Scheme Implementation Deed
|
|
KSD
|
59 |
20K |
2 |
17/03/25 |
17/03/25 |
ASX - By Stock
|
59
|
20K
|
2
|
|
ASX - By Stock
|
DNA |
Re:
Ann: DNA enters Scheme Implementation Deed
|
|
KSD
|
59 |
20K |
5 |
17/03/25 |
17/03/25 |
ASX - By Stock
|
59
|
20K
|
5
|
|
ASX - By Stock
|
BCI |
Re:
Ann: ASX CEO Connect Presentation
|
|
KSD
|
13 |
6.3K |
1 |
04/03/25 |
04/03/25 |
ASX - By Stock
|
13
|
6.3K
|
1
|
|
ASX - By Stock
|
BCI |
Re:
Ann: December 2024 Quarterly Update
|
|
KSD
|
44 |
18K |
0 |
27/02/25 |
27/02/25 |
ASX - By Stock
|
44
|
18K
|
0
|
|
ASX - By Stock
|
BCI |
Re:
Potash
|
|
KSD
|
15 |
6.5K |
0 |
26/02/25 |
26/02/25 |
ASX - By Stock
|
15
|
6.5K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
What is going on?
|
|
KSD
|
27 |
12K |
11 |
18/02/25 |
18/02/25 |
ASX - By Stock
|
27
|
12K
|
11
|
|
ASX - By Stock
|
EML |
Re:
Why EML could be a deep-value turnaround play
|
|
KSD
|
12 |
8.2K |
2 |
14/02/25 |
14/02/25 |
ASX - By Stock
|
12
|
8.2K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Statement of CDIs on issue - AVR
|
|
KSD
|
11 |
5.6K |
3 |
12/02/25 |
12/02/25 |
ASX - By Stock
|
11
|
5.6K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
A nice interview on the Medical Alley Podcast.
|
|
KSD
|
16 |
6.5K |
9 |
11/02/25 |
11/02/25 |
ASX - By Stock
|
16
|
6.5K
|
9
|
|
ASX - By Stock
|
BCI |
Re:
Ann: December 2024 Quarterly Update
|
|
KSD
|
44 |
18K |
0 |
04/02/25 |
04/02/25 |
ASX - By Stock
|
44
|
18K
|
0
|
|
ASX - By Stock
|
BCI |
Re:
Ann: December 2024 Quarterly Update
|
|
KSD
|
44 |
18K |
0 |
04/02/25 |
04/02/25 |
ASX - By Stock
|
44
|
18K
|
0
|
|
ASX - By Stock
|
DNA |
Re:
Ann: Quarterly Activities and Cashflow Reports
|
|
KSD
|
15 |
5.1K |
1 |
04/02/25 |
04/02/25 |
ASX - By Stock
|
15
|
5.1K
|
1
|
|
ASX - By Stock
|
DNA |
Re:
Ann: Quarterly Activities and Cashflow Reports
|
|
KSD
|
15 |
5.1K |
0 |
31/01/25 |
31/01/25 |
ASX - By Stock
|
15
|
5.1K
|
0
|
|
ASX - By Stock
|
EML |
Re:
Ann: Advance Notice - EML FY25 Interim Results Presentation
|
|
KSD
|
5 |
4.2K |
3 |
26/01/25 |
26/01/25 |
ASX - By Stock
|
5
|
4.2K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Lake Street research report focuses on valuation disconnect.
|
|
KSD
|
59 |
31K |
0 |
16/01/25 |
16/01/25 |
ASX - By Stock
|
59
|
31K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Equity Incentive Plan
|
|
KSD
|
64 |
29K |
2 |
31/12/24 |
31/12/24 |
ASX - By Stock
|
64
|
29K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Equity Incentive Plan
|
|
KSD
|
64 |
29K |
2 |
30/12/24 |
30/12/24 |
ASX - By Stock
|
64
|
29K
|
2
|
|